Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015
Author(s) -
Kaitlin Benedict,
Monika Roy,
Sarah Kabbani,
Evan J. Anderson,
Monica M. Farley,
Sasha Harb,
Lee H. Harrison,
Lindsay Bonner,
Vijitha Lahanda Wadu,
Kaytlyn Marceaux,
Rosemary Hollick,
Zintar G. Beldavs,
Alexia Y. Zhang,
William Schaffner,
Caroline R Graber,
Gordana Derado,
Tom Chiller,
Shawn R. Lockhart,
Snigdha Vallabhaneni
Publication year - 2018
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piy009
Subject(s) - medicine , incidence (geometry) , fluconazole , pediatrics , population , candida albicans , drug resistance , epidemiology , echinocandin , antifungal drug , antifungal , microbiology and biotechnology , environmental health , biology , physics , dermatology , optics
Candida is a leading cause of healthcare-associated bloodstream infections in the United States. Infants and children have unique risk factors for candidemia, and the Candida species distribution in this group is different that among adults; however, candidemia epidemiology in this population has not been described recently.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom